Results 61 to 70 of about 87,961 (202)

Role of surgery in oligometastatic prostate cancer

open access: yesProstate International, 2019
Androgen deprivation therapy as single modality therapy was the standard management for oligometastatic prostate cancer (PCa). Current paradigm shifts toward a multimodality therapy approach, targeting all sites of disease, including treatment of the ...
Pocharapong Jenjitranant   +1 more
doaj   +1 more source

Clinical outcomes and costs of robotic surgery in prostate cancer: a multiinstitutional study in Korea

open access: yesProstate International, 2019
Background: This study compared the surgical, functional, and oncologic outcomes of robot-assisted laparoscopic radical prostatectomy (RALP), laparoscopic radical prostatectomy (LRP), and retropubic radical prostatectomy (RRP) in Korean men. Methods: The
Ji Eun Yun   +9 more
doaj   +1 more source

Androgen receptor phosphorylation at serine 515 by Cdk1 predicts biochemical relapse in prostate cancer patients [PDF]

open access: yes, 2013
<br>Background:Prostate cancer cell growth is dependent upon androgen receptor (AR) activation, which is regulated by specific kinases. The aim of the current study is to establish if AR phosphorylation by Cdk1 or ERK1/2 is of prognostic ...
BV Kallakury   +40 more
core   +1 more source

Accuracy of multiparametric magnetic resonance imaging to detect significant prostate cancer and index lesion location [PDF]

open access: yes, 2018
Background: Multiparametric magnetic resonance imaging (mpMRI) of the prostate appears to improve prostate cancer detection, but studies comparing mpMRI to histopathology at the time of radical prostatectomy (RP) are lacking.
Duncan, Ian   +6 more
core   +1 more source

Stress Urinary Incontinence post-Holmium Laser Enucleation of the Prostate: a Single-Surgeon Experience. [PDF]

open access: yes, 2020
PURPOSE: To identify incidence and predictors of stress urinary incontinence (SUI) following Holmium laser enucleation of the prostate (HoLEP). MATERIALS AND METHODS: We performed a retrospective review of 589 HoLEP patients from 2012-2018. Patients were
Chandrasekar, Thenappan   +6 more
core   +1 more source

Predicting Prostate Cancer Aggressiveness through a Nanoparticle Test [PDF]

open access: yes, 2011
Prostate cancer (PCa) is the most common malignancy and the second leading cause of cancer death in American men. Due to the lack of accurate tests to distinguish aggressive cancer from indolent tumor, prostate cancer is often over-treated.
David Decker   +5 more
core   +1 more source

Adjuvant vs. salvage radiation therapy in men with high-risk features after radical prostatectomy: Survey of North American genitourinary expert radiation oncologists [PDF]

open access: yes, 2019
INTRODUCTION: The management of patients with high-risk features after radical prostatectomy (RP) is controversial. Level 1 evidence demonstrates that adjuvant radiation therapy (RT) improves survival compared to no treatment; however, it may ...
Chen, Yiyi   +4 more
core   +1 more source

The primacy of multiparametric MRI in men with suspected prostate cancer [PDF]

open access: yes, 2019
Background: Multiparametric MRI (mpMRI) became recognised in investigating those with suspected prostate cancer between 2010 and 2012; in the USA, the preventative task force moratorium on PSA screening was a strong catalyst. In a few short years, it has
Logager, V.   +5 more
core   +5 more sources

Robot-assisted radical prostatectomy with da Vinci single-port system

open access: yesJournal of Education, Health and Sport
Introduction and purpose Prostate cancer is the most common malignant tumor in men in Poland. In 2021, the standardized incidence rate was 48.2 cases per 100,000 people. It is diagnosed mainly in men over 60 years of age.
Marek Kurowski   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy